Biomedical Research

VHB plays an important role in delivering mission-critical certainty for biotechnology, pharmaceutical, and life sciences firms needing to build, modernize, or expand. It’s no wonder that world class corporations like Bristol Myers Squibb and Pfizer look to VHB to bring their local knowledge, technical excellence, and quality assurance to help them move their project from site selection to commissioning to market—on time, on budget, and within compliance. We get results because we understand that these facilities must be designed with utmost flexibility, be scalable, and be up and running quickly since every second gained is a competitive advantage and possibly worth millions. Armed with years of experience delivering high-quality research and development, and commercial-scale manufacturing facilities, you can count on VHB to bring certainty to the mission-critical process.


  • Alexandria Real Estate Equities

  • Altria Group

  • Amgen, Inc.

  • Arranta Bio

  • AstraZeneca Pharmaceuticals LP

  • BioMed Realty Trust, Inc.

  • Biogen

  • Boston Properties, Inc.

  • Boston Scientific Corporation

  • Bristol Myers Squibb Company

  • Dana Farber Cancer Institute

  • Fluor Enterprises, Inc

  • Genetics Institute

  • IQHQ Properties

  • LifeNet

  • MIT Lincoln Lab

  • National Development

  • Novartis Institute for Biomedical Research

  • Partners HealthCare

  • Pfizer

  • Sanofi

  • The Broad Institute​

Mark Junghans is a Managing Director of Land Development at VHB.

Mark Junghans

Managing Director, Land Development